Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jan 12;6(5):708–720. doi: 10.1016/j.cjco.2024.01.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Forest plot for (A) major adverse cardiovascular events, (B) death, (C) stent thrombosis, and (D) bleeding. ACS, acute coronary syndrome; AUGUSTUS, Apixaban Versus Warfarin in Patients with AF and ACS or PCI; CI, confidence interval; DOAC, direct oral anticoagulant; ENTRUST, Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENTRUST-AF-PCI); M-H, Mantel-Haenszel; PCI, percutaneous coronary intervention; PIONEER, Exploration of Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo a Percutaneous Coronary Intervention (PIONEER-AF PCI); P2Y12i, P2Y12 inhibitor; RE-DUAL, Randomized Evaluation of Dual Therapy With Dabigatran vs Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (RE-DUAL PCI).

Forest plot for (A) major adverse cardiovascular events, (B) death, (C) stent thrombosis, and (D) bleeding. ACS, acute coronary syndrome; AUGUSTUS, Apixaban Versus Warfarin in Patients with AF and ACS or PCI; CI, confidence interval; DOAC, direct oral anticoagulant; ENTRUST, Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENTRUST-AF-PCI); M-H, Mantel-Haenszel; PCI, percutaneous coronary intervention; PIONEER, Exploration of Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo a Percutaneous Coronary Intervention (PIONEER-AF PCI); P2Y12i, P2Y12 inhibitor; RE-DUAL, Randomized Evaluation of Dual Therapy With Dabigatran vs Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (RE-DUAL PCI).